Boston Scientific Corp.
(NYSE : BSX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp. -0.34%265.520.7%$613.38m
TMOThermo Fisher Scientific, Inc. 0.14%521.001.0%$590.41m
MDTMedtronic Plc -0.99%82.730.6%$545.15m
ABTAbbott Laboratories -0.32%100.750.8%$528.64m
ISRGIntuitive Surgical, Inc. -0.29%190.520.8%$345.03m
SYKStryker Corp. -0.91%206.981.3%$289.15m
BSXBoston Scientific Corp. -1.02%38.901.0%$254.76m
BDXBecton, Dickinson & Co. -1.32%234.061.0%$240.65m
EWEdwards Lifesciences Corp. 0.71%84.770.4%$238.81m
DXCMDexCom, Inc. -0.37%80.661.9%$189.15m
AAgilent Technologies, Inc. -0.73%123.481.7%$183.21m
IDXXIDEXX Laboratories, Inc. 2.49%334.203.9%$173.71m
ALGNAlign Technology, Inc. 2.06%222.436.4%$172.49m
BAXBaxter International, Inc. 0.11%55.431.8%$166.03m
NEOGNeogen Corp. -1.20%14.790.5%$151.45m

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment consists of technologies for diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979, and is headquartered in Marlborough, MA.